Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner | 11 | $181.8K | $504.8K | 2026-07-14 |
| Tung Joseph | Director | 1 | $0 | $0 | 2025-08-08 |
| Nabyt Oleh | Director | 1 | $0 | $0 | 2025-08-08 |
| Scorsis George | Director | 1 | $0 | $0 | 2025-08-08 |
| Lorber Timothy J. | Chief Financial Officer | 2 | $0 | $0 | 2025-08-08 |
| Richards Steven M | Director | 2 | $0 | $1.6K | 2025-08-08 |
| Jung Mira | Chief Scientific Officer | 2 | $0 | $528 | 2024-05-01 |
| Vander Hoek Michael | Chief Financial Officer | 2 | $0 | $3.6K | 2024-03-08 |
| Jacobs Bette | Director | 2 | $0 | $8.9K | 2023-12-13 |
| Brown Milton | Director | 3 | $0 | $2.9K | 2023-12-13 |
| Dritschilo Anatoly | CEO and Chairman | 3 | $0 | $13.5K | 2023-08-14 |
| Senanayake Chris | Director | 1 | $0 | $2.6K | 2022-12-29 |
| Adkins William | Other | 2 | $0 | $1.6K | 2022-12-29 |
| Rich Tyvin | Chief Medical Officer | 1 | $0 | $2.3K | 2022-12-29 |
| Dritschilo Peter | President and COO | 1 | $0 | $6.2K | 2022-12-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner | S Sale | 2026-07-14 | 2026-07-15 | 82,116 | $4.48 | $367.9K | 0 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | S Sale | 2026-07-13 | 2026-07-15 | 1,033 | $4.67 | $4.8K | 60,238 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | P Buy | 2026-07-10 | 2026-07-13 | 731 | $3.11 | $2.3K | 61,271 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | P Buy | 2026-07-09 | 2026-07-13 | 8,266 | $3.38 | $27.9K | 60,540 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | S Sale | 2026-07-08 | 2026-07-09 | 18,531 | $3.52 | $65.2K | 52,274 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | S Sale | 2026-07-07 | 2026-07-09 | 10,580 | $3.33 | $35.2K | 70,805 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | S Sale | 2026-07-06 | 2026-07-07 | 9,022 | $3.51 | $31.7K | 81,385 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | P Buy | 2026-07-02 | 2026-07-07 | 7,851 | $3.54 | $27.8K | 90,407 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | P Buy | 2026-07-01 | 2026-07-02 | 3,959 | $3.30 | $13.1K | 82,556 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | P Buy | 2026-06-30 | 2026-07-01 | 6,755 | $3.23 | $21.8K | 78,597 | SEC↗ |
| HRT FINANCIAL LP | 10% Owner | P Buy | 2026-06-29 | 2026-07-01 | 25,836 | $3.44 | $88.9K | 71,842 | SEC↗ |
| Lorber Timothy J. | Chief Financial Officer | A Award deriv | 2025-08-08 | 2025-08-12 | 24,854 | — | $0 | 24,854 | SEC↗ |
| Lorber Timothy J. | Chief Financial Officer | A Award deriv | 2025-08-08 | 2025-08-12 | 29,240 | — | $0 | 29,240 | SEC↗ |
| Tung Joseph | Director | A Award deriv | 2025-08-08 | 2025-08-12 | 29,240 | — | $0 | 29,240 | SEC↗ |
| Scorsis George | Director | A Award deriv | 2025-08-08 | 2025-08-12 | 29,240 | — | $0 | 29,240 | SEC↗ |
| Nabyt Oleh | Director | A Award deriv | 2025-08-08 | 2025-08-12 | 29,240 | — | $0 | 29,240 | SEC↗ |
| Richards Steven M | Director | A Award deriv | 2025-08-08 | 2025-08-13 | 29,240 | — | $0 | 29,240 | SEC↗ |
| Jung Mira | Chief Scientific Officer | A Award | 2024-05-01 | 2024-10-09 | 598 | $11.28 | $6.7K | 135,715 | SEC↗ |
| Vander Hoek Michael | Chief Financial Officer | A Award | 2024-03-08 | 2024-03-08 | 100,000 | — | $0 | 103,852 | SEC↗ |
| Brown Milton | Director | S Sale | 2023-12-13 | 2024-01-02 | 2,921 | $0.46 | $1.3K | 1,094,610 | SEC↗ |
| Jacobs Bette | Director | S Sale | 2023-12-13 | 2023-12-20 | 4,157 | $0.46 | $1.9K | 27,064 | SEC↗ |
| Dritschilo Anatoly | CEO and Chairman | G Gift | 2023-08-14 | 2023-08-18 | 2,100,000 | — | $0 | 1,104,407 | SEC↗ |
| Dritschilo Anatoly | CEO and Chairman | G Gift | 2023-08-14 | 2023-08-18 | 2,100,000 | — | $0 | 2,100,000 | SEC↗ |
| Brown Milton | Director | A Award deriv | 2023-02-15 | 2023-02-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Senanayake Chris | Director | S Sale | 2022-12-29 | 2024-03-14 | 1,626 | $1.61 | $2.6K | 2,791 | SEC↗ |
| Jacobs Bette | Director | S Sale | 2022-12-29 | 2023-01-03 | 4,366 | $1.61 | $7.0K | 31,221 | SEC↗ |
| Jung Mira | Chief Scientific Officer | S Sale | 2022-12-29 | 2023-01-03 | 328 | $1.61 | $528 | 1,071,388 | SEC↗ |
| Rich Tyvin | Chief Medical Officer | S Sale | 2022-12-29 | 2023-01-03 | 1,414 | $1.61 | $2.3K | 2,429 | SEC↗ |
| Dritschilo Anatoly | CEO and Chairman | S Sale | 2022-12-29 | 2023-01-03 | 8,372 | $1.61 | $13.5K | 1,085,200 | SEC↗ |
| Brown Milton | Director | S Sale | 2022-12-29 | 2023-01-04 | 995 | $1.61 | $1.6K | 1,072,531 | SEC↗ |
| Adkins William | Other | S Sale | 2022-12-29 | 2023-01-04 | 995 | $1.61 | $1.6K | 184,071 | SEC↗ |
| Richards Steven M | Director | S Sale | 2022-12-29 | 2023-01-09 | 995 | $1.61 | $1.6K | 1,707 | SEC↗ |
| Vander Hoek Michael | Chief Financial Officer | S Sale | 2022-12-29 | 2022-12-30 | 2,243 | $1.61 | $3.6K | 3,852 | SEC↗ |
| Dritschilo Peter | President and COO | S Sale | 2022-12-29 | 2022-12-30 | 3,820 | $1.61 | $6.2K | 6,560 | SEC↗ |
| Adkins William | Other | J Other deriv | 2022-09-02 | 2023-01-04 | 138,889 | — | $0 | 138,889 | SEC↗ |